Richard Littlewood

Diamond Light Source Ltd
Didcot, ENG OX110DE, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Droplet-on-demand tape drive and X-ray emission spectroscopy prototypes for time-resolved serial crystallography on VMXi at Diamond Light Source.

Droplet-on-demand tape drive and X-ray emission spectroscopy prototypes for time-resolved serial crystallography on VMXi at Diamond Light Source.

Journal: IUCrJ

Published: July 30, 2026

A novel glucose beta-hydroxybutyrate combination improves hypoglycaemia recovery and patient-reported outcomes in type 1 diabetes.

A novel glucose beta-hydroxybutyrate combination improves hypoglycaemia recovery and patient-reported outcomes in type 1 diabetes.

Journal: Diabetes, obesity & metabolism

Published: October 29, 2025

VMXm - A sub-micron focus macromolecular crystallography beamline at Diamond Light Source.

VMXm - A sub-micron focus macromolecular crystallography beamline at Diamond Light Source.

Journal: Journal of synchrotron radiation

Published: March 06, 2024

Prolonged-Release Buprenorphine Therapy in Opioid Use Disorder Can Address Stigma and Improve Patient Quality of Life.

Prolonged-Release Buprenorphine Therapy in Opioid Use Disorder Can Address Stigma and Improve Patient Quality of Life.

Journal: Cureus

Published: October 05, 2021

Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine.

Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine.

Journal: Substance abuse and rehabilitation

Published: June 09, 2020

COVID19 pandemic and people with opioid use disorder: innovation to reduce risk.

COVID19 pandemic and people with opioid use disorder: innovation to reduce risk.

Journal: Psychiatry research

Published: April 23, 2020

OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis.

OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: April 03, 2020

Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder.

Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder.

Journal: Hepatic medicine : evidence and research

Published: January 08, 2019

Current and future options for opioid use disorder: a survey assessing real-world opinion of service users on novel therapies including depot formulations of buprenorphine.

Current and future options for opioid use disorder: a survey assessing real-world opinion of service users on novel therapies including depot formulations of buprenorphine.

Journal: Patient preference and adherence

Published: October 24, 2018

Standards for opioid use disorder care: An assessment of Nordic approaches.

Standards for opioid use disorder care: An assessment of Nordic approaches.

Journal: Nordisk alkohol- & narkotikatidskrift : NAT

Published: June 18, 2018

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.

Journal: BMC public health

Published: May 10, 2018

Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice.

Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice.

Journal: Substance abuse treatment, prevention, and policy

Published: March 08, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026